privacy | investment disclaimer | contact us
Excorp Medical's Bioartificial Liver System comprises a reusable instrument, disposable tubing set and the proprietary, disposable bioartificail reactor.Once approved by regulatory agencies, Excorp Medical expects this breakthrough Bioartificial Liver System technology to be both live-saving and cost effective.Certain drugs or machines are available to substitute temporarily or long-term for many organs in the body…  no comparable substitute has been developed for the liver.The liver is the largest organ in the body and performs a variety of tasks impacting all body systems… as a result liver disease has widespread effects on virtually all other organs.Excorp Medical is currently the only company approved to conduct bioartificial liver human trials within the U.S.Currently patients must receive a liver transplant or endure prolonged hospitalization at great expense to have a chance at survival.Excorp Medical Bioartificial Liver System treatments serve as a bridge to liver regeneration and transplantExcorp Medical has developed a Bioartificial Liver System for the metabolic support of patients with compromised liver function.
Chinese Simplified
简体中文
Chinese Traditional
繁體中文
Arabic

Company


Excorp Medical, Inc., established November 22, 1995, is a Corporation headquartered and registered in the state of Minnesota in the US. It has a Wholly Foreign Owned Entity (WFOE) in Wu’xi, JiangSu Province, China and a Wholly Foreign Owned Subsidiary (WFOS) in Hong Kong, China. Further locations are planned to include a joint venture, Shinva Excorp Bioscience Corp, Ltd., in Zibo, Shandong Province, China and a manufacturing facility, Loudi Excorp Manufacturing Company, Ltd., in Loudi, Hunan Province, China.

The near term goal of Excorp Medical, Inc. and its entities is to provide a profitable, cost effective, temporary liver assist system for patients in acute liver failure supporting a patient’s own liver regeneration or until a liver transplant can be performed.

Globally, our long term goal is to make this potentially life-saving, cost effective technology widely available on an expedited basis.


home | introduction | bioartificial liver system | company | management
news | affiliates | publications | clinical trials | shareholders' corner | careers | investors
links & resources | privacy | investment disclaimer | contact us


news
affiliates
publications
clinical trials
careers
investors
links & resources
©2014 Excorp Medical, Inc.